1. Home
  2. INKT vs CPIX Comparison

INKT vs CPIX Comparison

Compare INKT & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INKT
  • CPIX
  • Stock Information
  • Founded
  • INKT 2017
  • CPIX 1999
  • Country
  • INKT United States
  • CPIX United States
  • Employees
  • INKT N/A
  • CPIX N/A
  • Industry
  • INKT Medicinal Chemicals and Botanical Products
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INKT Health Care
  • CPIX Health Care
  • Exchange
  • INKT Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • INKT 43.0M
  • CPIX 35.4M
  • IPO Year
  • INKT 2021
  • CPIX 2009
  • Fundamental
  • Price
  • INKT $11.00
  • CPIX $4.64
  • Analyst Decision
  • INKT Strong Buy
  • CPIX
  • Analyst Count
  • INKT 2
  • CPIX 0
  • Target Price
  • INKT $6.50
  • CPIX N/A
  • AVG Volume (30 Days)
  • INKT 71.7K
  • CPIX 4.5M
  • Earning Date
  • INKT 03-20-2025
  • CPIX 03-04-2025
  • Dividend Yield
  • INKT N/A
  • CPIX N/A
  • EPS Growth
  • INKT N/A
  • CPIX N/A
  • EPS
  • INKT N/A
  • CPIX N/A
  • Revenue
  • INKT N/A
  • CPIX $36,785,442.00
  • Revenue This Year
  • INKT N/A
  • CPIX N/A
  • Revenue Next Year
  • INKT N/A
  • CPIX N/A
  • P/E Ratio
  • INKT N/A
  • CPIX N/A
  • Revenue Growth
  • INKT N/A
  • CPIX N/A
  • 52 Week Low
  • INKT $4.56
  • CPIX $1.04
  • 52 Week High
  • INKT $19.00
  • CPIX $6.43
  • Technical
  • Relative Strength Index (RSI)
  • INKT 59.75
  • CPIX 83.81
  • Support Level
  • INKT $7.32
  • CPIX $2.08
  • Resistance Level
  • INKT $13.79
  • CPIX $6.43
  • Average True Range (ATR)
  • INKT 2.07
  • CPIX 0.53
  • MACD
  • INKT 0.28
  • CPIX 0.27
  • Stochastic Oscillator
  • INKT 71.94
  • CPIX 74.94

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: